Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
SCIENTIFIC REFERENCES Love, S., & Coakham, H
its relevance to retatrutide specifically is not yet established A history of pancreatitis or significant gastrointestinal disease Gallbladder disease , including a history of gallstones or cholecystitis Diabetes mellitus , particularly if managed with insulin or sulphonylureas, due to hypoglycaemia risk Cardiovascular disease , including arrhythmias or recent cardiac events Renal or hepatic impairment , which may affect tolerability and increase the risk of dehydration-related complications Pregnancy or breastfeeding no safety data exist for retatrutide in these groups Use of oral medicines where absorption may be affected by delayed gastric emptying , such as levothyroxine or combined oral contraceptives Seek urgent medical attention if you experience severe or persistent nausea or vomiting, persistent abdominal pain (which may indicate pancreatitis or gallbladder disease), signs of an allergic reaction (rash, swelling, difficulty breathing), chest pain, palpitations, or signs of dehydration
Consult your healthcare professional before use if you are pregnant, breastfeeding, have any medical condition, or are taking other medications
Always follow your clinicians specific instructions
Additionally, the lack of sensation in the feet, often overlooked by patients, can lead to insensate injuries, falls, foot ulceration, and even amputation, underscoring the urgent need for early identification and intervention [2, 14,15,16]
